Atyr Pharma Inc’s recently made public that its Director Gross Jane A acquired Company’s shares for reported $15000.0 on Mar 17 ’25. In the deal valued at $4.00 per share,3,750 shares were bought. As a result of this transaction, Gross Jane A now holds 9,750 shares worth roughly $30225.0.
Then, Broadfoot Jill Marie sold 1,254 shares, generating $4,740 in total proceeds. Upon selling the shares at $3.78, the Chief Financial Officer now owns 31,763 shares.
Before that, DENYES NANCY sold 899 shares. Atyr Pharma Inc shares valued at $3,398 were divested by the General Counsel at a price of $3.78 per share. As a result of the transaction, DENYES NANCY now holds 26,555 shares, worth roughly $82320.5.
Leerink Partners initiated its Atyr Pharma Inc [ATYR] rating to an Outperform in a research note published on February 18, 2025; the price target was $16. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Wells Fargo began covering ATYR with “an Overweight” recommendation on October 04, 2024. Jefferies started covering the stock on September 05, 2024. It rated ATYR as “a Buy”.
Price Performance Review of ATYR
On Thursday, Atyr Pharma Inc [NASDAQ:ATYR] saw its stock jump 2.65% to $3.10. Over the last five days, the stock has gained 13.14%. Atyr Pharma Inc shares have fallen nearly -14.36% since the year began. Nevertheless, the stocks have risen 92.55% over the past one year. While a 52-week high of $4.66 was reached on 02/21/25, a 52-week low of $1.42 was recorded on 04/07/25. SMA at 50 days reached $3.44, while 200 days put it at $2.82.
Levels Of Support And Resistance For ATYR Stock
The 24-hour chart illustrates a support level at 3.00, which if violated will result in even more drops to 2.90. On the upside, there is a resistance level at 3.17. A further resistance level may holdings at 3.24. The Relative Strength Index (RSI) on the 14-day chart is 48.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 5.88%. Stochastics %K at 78.49% indicates the stock is a holding.
How much short interest is there in Atyr Pharma Inc?
A steep rise in short interest was recorded in Atyr Pharma Inc stocks on 2025-03-31, growing by 3.06 million shares to a total of 8.32 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 5.26 million shares. There was a rise of 36.81%, which implies that there is a positive sentiment for the stock.
